Spearhead Capital Advisors’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-4,547
Closed -$703K – 235
2021
Q4
$703K Buy
4,547
+44
+1% +$7.37K 0.08% 76
2021
Q3
$765K Buy
4,503
+43
+1% +$6.69K 0.1% 68
2021
Q2
$704K Buy
4,460
+394
+10% +$58.5K 0.1% 76
2021
Q1
$565K Buy
4,066
+406
+11% +$65.4K 0.08% 78
2020
Q4
$641K Buy
3,660
+36
+1% +$6.71K 0.1% 82
2020
Q3
$709K Buy
3,624
+238
+7% +$39.8K 0.14% 67
2020
Q2
$575K Buy
3,386
+274
+9% +$40.9K 0.12% 71
2020
Q1
$359K Buy
+3,112
New +$345K 0.1% 83

Other funds holding SGEN

Spearhead Capital Advisors's SGEN Position: Q1 2022 in Review

Spearhead Capital Advisors sold out of Seagen Inc. Common Stock (SGEN) in Q1 2022, closing a stake of 4,547 shares — an estimated $703K sold.

Spearhead Capital Advisors first reported a position in SGEN in Q1 2020 and held it in 8 quarters. The position peaked at $765K in Q3 2021. 505 funds tracked by Wall St. Rank hold SGEN as of Q1 2022.

  • Spearhead Capital Advisors reported no remaining Seagen Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Spearhead Capital Advisors sold 4,547 Seagen Inc. Common Stock shares in Q1 2022, an estimated $703K.
  • Spearhead Capital Advisors first reported a position in Seagen Inc. Common Stock in Q1 2020 and held it in 8 quarters.
  • Spearhead Capital Advisors's Seagen Inc. Common Stock position peaked at $765K in Q3 2021.
  • 505 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2022.

Based on Spearhead Capital Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.